TINS, target immobilized NMR screening: An efficient and sensitive method for ligand discovery

Chemistry and Biology

Volumn 12, Issue 2, 2005, Pages 207-216

  Vanwetswinkel, Sophie ^a   Heetebrij, Robert J ^a   Van Duynhoven, John ^c   Hollander, Johan G ^a   Filippov, Dmitri V ^a   Hajduk, Philip J ^b   Siegal, Gregg ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b ABBOTT LABORATORIES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 14144250362     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.12.004     Document Type: Article

References (34)

1. T.I. Oprea, A.M. Davis, S.J. Teague, and P.D. Leeson Is there a difference between leads and drugs? A historical perspective J. Chem. Inf. Comput. Sci. 41 2001 1308 1315
2. S.J. Teague, A.M. Davis, P.D. Leeson, and T. Oprea The design of leadlike combinatorial libraries Angew. Chem. Int. Ed. Engl. 38 1999 3743 3748
3. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
4. S.B. Shuker, P.J. Hajduk, R.P. Meadows, and S.W. Fesik Discovering high-affinity ligands for proteins: SAR by NMR Science 274 1996 1531 1534
5. P.J. Hajduk, R.P. Meadows, and S.W. Fesik Drug design: Discovering high-affinity ligands for proteins Science 278 1997 497 499
6. A. Lanir, and G. Navon Nuclear magnetic resonance studies of bovine carbonic anhydrase. Binding of sulfonamides to the zinc enzyme Biochemistry 10 1971 1024 1032
7. P.J. Hajduk, D.J. Augeri, J. Mack, R. Mendoza, J.G. Yang, S.F. Betz, and S.W. Fesik NMR-based screening of proteins containing C-13-labeled methyl groups J. Am. Chem. Soc. 122 2000 7898 7904
8. P.J. Hajduk, M.M. Zhou, and S.W. Fesik NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain Bioorg. Med. Chem. Lett. 9 1999 2403 2406
9. P.J. Hajduk, J.C. Mack, E.T. Olejniczak, C. Park, P.J. Dandliker, and B.A. Beutel SOS-NMR: A saturation transfer NMR-based method for determining the structures of protein-ligand complexes J. Am. Chem. Soc. 126 2004 2390 2398
10. M. Pellecchia, D. Meininger, Q. Dong, E. Chang, R. Jack, and D.S. Sem NMR-based structural characterization of large protein-ligand interactions J. Biomol. NMR 22 2002 165 173
11. P.J. Hajduk, E.T. Olejniczak, and S.W. Fesik One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules J. Am. Chem. Soc. 119 1997 12257 12261
12. K. Bleicher, M.F. Lin, M.J. Shapiro, and J.R. Wareing Diffusion edited NMR: Screening compound mixtures by affinity NMR to detect binding ligands to vancomycin J. Org. Chem. 63 1998 8486 8490
13. R.C. Anderson, M.F. Lin, and M.J. Shapiro Affinity NMR: Decoding DNA binding J. Comb. Chem. 1 1999 69 72
14. J. Fejzo, C.A. Lepre, J.W. Peng, G.W. Bemis, M.A. Murcko, and J.M. Moore The SHAPES strategy: an NMR-based approach for lead generation in drug discovery Chem. Biol. 6 1999 755 769
15. D. Henrichsen, B. Ernst, J.L. Magnani, W.T. Wang, B. Meyer, and T. Peters Bioaffinity NMR spectroscopy: Identification of an E-selectin antagonist in a substance mixture by transfer NOE Angew. Chem. Int. Ed. Engl. 38 1999 98 102
16. A.D. Chen, and M.J. Shapiro NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR J. Am. Chem. Soc. 122 2000 414 415
17. C. Dalvit, P. Pevarello, M. Tato, M. Veronesi, A. Vulpetti, and M. Sundstrom Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water J. Biomol. NMR 18 2000 65 68
18. B. Meyer, T. Weimar, and T. Peters Screening mixtures for biological activity by NMR Eur. J. Biochem. 246 1997 705 709
19. J. Klein, R. Meinecke, M. Mayer, and B. Meyer Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NMR J. Am. Chem. Soc. 121 1999 5336 5337
20. C. Dalvit, M. Flocco, M. Veronesi, and B.J. Stockman Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures Comb. Chem. High Throughput Screen. 5 2002 605 611
21. A. Bhunia, V. Jayalakshmi, A.J. Benie, O. Schuster, S. Kelm, N.R. Krishna, and T. Peters Saturation transfer difference NMR and computational modeling of a sialoadhesin-sialyl lactose complex Carbohydr. Res. 339 2004 259 267
22. B.J. Stockman, and C. Dalvit NMR screening techniques in drug discovery and drug design Prog. NMR Spectrosc. 41 2002 187 231
23. Y.S. Wang, D.J. Liu, and D.F. Wyss Competition STD NMR for the detection of high-affinity ligands and NMR-based screening Magn. Reson. Chem. 42 2004 485 489
24. W.H. Gmeiner, C.J. Hudalla, A.M. Soto, and L. Marky Binding of ethidium to DNA measured using a 2D diffusion- modulated gradient COSYNMR experiment FEBS Lett. 465 2000 148 152
25. R. Meinecke, and B. Meyer Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alpha(IIb)beta(3) J. Med. Chem. 44 2001 3059 3065
26. W.H. Braunlin, T.J. Strick, and M.T. Record Equilibrium Dialysis Studies of Polyamine Binding to DNA Biopolymers 21 1982 1301 1314
27. I. Muegge, Y.C. Martin, P.J. Hajduk, and S.W. Fesik Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein J. Med. Chem. 42 1999 2498 2503
28. J.C. Lindon, E. Holmes, and J.K. Nicholson Pattern recognition methods and applications in biomedical magnetic resonance Prog. NMR Spectrosc. 39 2001 1 40
29. E. Piccione, R.D. Case, S.M. Domchek, P. Hu, M. Chaudhuri, J.M. Backer, J. Schlessinger, and S.E. Shoelson Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding Biochemistry 32 1993 3197 3202
30. A.L. Breeze, B.V. Kara, D.G. Barratt, M. Anderson, J.C. Smith, R.W. Luke, J.R. Best, and S.A. Cartlidge Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase EMBO J. 15 1996 3579 3589
31. B. Ye, M. Akamatsu, S.E. Shoelson, G. Wolf, S. Giorgetti-Peraldi, X.J. Yan, P.P. Roller, and T.R. Burke L-O-(2-Malonyl)Tyrosine: A new phosphotyrosyl mimetic for the preparation of Src-homology-2 domain inhibitory peptides J. Med. Chem. 38 1995 4270 4275
32. J.M. Moore, D.A. Peattie, M.J. Fitzgibbon, and J.A. Thomson Solution structure of the major binding-protein for the immunosuppressant Fk506 Nature 351 1991 248 250
33. G. Siegal, B. Davis, S.M. Kristensen, A. Sankar, J. Linacre, R.C. Stein, G. Panayotou, M.D. Waterfield, and P.C. Driscoll Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase J. Mol. Biol. 276 1998 461 478
34. M. Piotto, V. Saudek, and V. Sklenar Gradient-tailored excitation for single-quantum NMR: spectroscopy of aqueous solutions J. Biomol. NMR 2 1992 661 665